Lithium Carbonate IP 450 mg: Uses, Benefits, Dosage, Side Effects & Precautions

Lithium Carbonate IP 450 mg is a prescription medicine primarily used as a mood stabilizer in the management of bipolar disorder and certain related mood conditions. ELCARBONATE 450 SR, marketed by Steris Healthcare, contains lithium carbonate in a sustained-release formulation. Because lithium has a relatively narrow therapeutic range, treatment requires careful medical supervision and, in many patients, periodic blood-level monitoring.

What is Lithium Carbonate IP 450 mg used for?

Lithium Carbonate IP 450 mg is used for the treatment and long-term management of manic episodes associated with bipolar disorder and for maintenance therapy to help reduce recurrence of significant mood episodes.

Lithium may help stabilize excessive mood elevation, irritability, impulsivity, and other symptoms associated with mania. It can also help reduce the likelihood of future manic episodes and, in appropriate patients, depressive episodes.

ELCARBONATE 450 SR should only be taken on prescription. It is not an ordinary nutritional lithium supplement, and the dose must be individualized according to clinical response, kidney function, age, other medicines, and serum lithium concentration.

Why it's important

Bipolar disorder can involve recurring episodes of mania, hypomania, and depression. Maintaining mood stability is an important part of long-term treatment.

Lithium has a well-established role as a mood stabilizer, but it requires greater monitoring than many commonly used medicines because the difference between an effective dose and a toxic concentration can be relatively small.

Adequate hydration and consistent salt intake are particularly important during lithium treatment. Significant dehydration, sudden dietary changes, excessive sweating, vomiting, or diarrhoea can alter lithium concentrations and potentially increase the risk of toxicity.

Key Benefits 

What are the benefits?

When appropriately prescribed and monitored, ELCARBONATE 450 SR may:

  • Help control manic symptoms associated with bipolar disorder.
  • Support long-term mood stabilization.
  • Reduce the recurrence of manic episodes.
  • Help maintain mood stability between episodes.
  • Reduce the risk of relapse in appropriately selected patients.
  • Provide sustained-release lithium delivery in a suitable formulation.

Lithium is not an immediate-relief medicine for every mood symptom. Its therapeutic effect and optimal dose vary from person to person, and treatment should be individualized by a psychiatrist or other qualified healthcare professional.

Side Effects 

Common or dose-related side effects may include:

  • Nausea
  • Diarrhoea
  • Fine hand tremor
  • Increased thirst
  • Increased urination
  • Mild fatigue
  • Weight gain
  • Metallic taste
  • Mild cognitive slowing
  • Acne or skin changes in some individuals

Some adverse effects may become more noticeable when lithium levels are higher. Persistent tremor, excessive thirst or urination, or gastrointestinal symptoms should be discussed with the treating doctor.

Serious Side Effects 

Lithium toxicity is a medical emergency. Seek urgent medical attention if symptoms such as the following develop:

  • Severe or worsening tremor
  • Marked muscle weakness
  • Difficulty walking or poor coordination
  • Slurred speech
  • Severe drowsiness or confusion
  • Persistent vomiting or severe diarrhoea
  • Blurred vision
  • Severe dizziness
  • Loss of consciousness
  • Seizures

Toxicity can occur if lithium levels become excessively high, particularly following dehydration, kidney impairment, significant changes in sodium intake, or interactions with certain medicines.

Available Substitute 

There is no universal substitute for ELCARBONATE 450 SR.

Depending on the diagnosis, symptoms, medical history, and treatment response, a healthcare professional may consider other mood stabilizers or psychiatric medicines, such as:

  • Valproate
  • Lamotrigine
  • Carbamazepine
  • Certain atypical antipsychotic medicines

These medicines do not have identical mechanisms, benefits, or safety profiles. The decision to switch treatment must therefore be made by the treating clinician.

Dosage Guidelines 

The appropriate dose of Lithium Carbonate IP 450 mg is individualized according to the patient's clinical condition and serum lithium concentration.

Because ELCARBONATE 450 SR is a sustained-release formulation, swallow it exactly as directed. Do not crush, chew, or split the tablet unless the specific product instructions state that it is safe to do so.

Lithium blood levels are commonly checked after treatment initiation and following dose changes. The exact target range depends on the indication, treatment phase, laboratory method, and individual clinical circumstances.

Take lithium consistently at approximately the same time each day and maintain adequate fluid intake.

If you miss a dose, follow your prescriber's instructions rather than taking extra lithium to compensate.

Precautions & Warnings

Before taking Lithium Carbonate IP 450 mg, tell your healthcare professional if you have:

  • Kidney disease
  • Thyroid disease
  • Heart disease
  • Significant dehydration
  • A history of electrolyte abnormalities
  • Severe or recurrent vomiting or diarrhoea
  • A low-salt diet
  • Pregnancy or plans to become pregnant
  • A history of lithium toxicity

Many medicines can affect lithium concentrations. Important examples include certain diuretics, ACE inhibitors, ARBs, and NSAID painkillers. Always inform your doctor and pharmacist that you are taking lithium before starting another medicine.

Maintain consistent fluid and dietary salt intake. Contact your healthcare professional promptly if you develop prolonged vomiting, diarrhoea, fever, heavy sweating, or another condition that may cause dehydration.

How to Use 

Take ELCARBONATE 450 SR exactly according to your prescription.

Swallow the sustained-release tablet with water. Do not independently increase, decrease, or discontinue the dose.

Take the medicine consistently in relation to meals if your healthcare professional has provided specific instructions. Maintain regular hydration.

Keep all scheduled appointments for serum lithium, kidney function, thyroid function, and other monitoring recommended by your doctor.

Do not begin over-the-counter medicines or supplements without checking whether they can interact with lithium.

Mechanism of Action

Lithium has a complex pharmacological mechanism and does not work through one single receptor.

After entering cells, lithium influences several intracellular signalling pathways involved in neuronal communication and mood regulation. It affects signalling systems involving enzymes and second-messenger pathways, including pathways associated with inositol metabolism and glycogen synthase kinase-3 (GSK-3).

Through these and other effects, lithium is believed to influence neuronal signalling, neurotransmitter regulation, cellular resilience, and neuroplasticity.

The precise mechanism responsible for its mood-stabilizing effects is not completely understood.

Because lithium is primarily eliminated through the kidneys, changes in renal function, hydration, and sodium balance can significantly affect lithium concentrations.

Monitoring During Lithium Treatment

Safe lithium therapy involves more than taking the prescribed tablet. Your healthcare professional may monitor:

  • Serum lithium concentration
  • Kidney function
  • Thyroid function
  • Electrolytes
  • Weight and general health
  • Clinical response and mood symptoms

Monitoring becomes especially important after starting therapy, changing the dose, adding interacting medicines, or experiencing significant illness or dehydration.

Conclusion

Lithium Carbonate IP 450 mg, marketed as ELCARBONATE 450 SR by Steris Healthcare, is an important prescription mood stabilizer used primarily for bipolar disorder and long-term mood stabilization.

Its effectiveness depends on achieving an appropriate lithium concentration while avoiding toxicity. This makes correct dosing, regular monitoring, adequate hydration, consistent salt intake, and awareness of drug interactions particularly important.

Patients should never alter their lithium dose or stop treatment abruptly without medical advice. If symptoms suggest lithium toxicity—especially severe tremor, vomiting, diarrhoea, confusion, poor coordination, extreme drowsiness, or seizures—urgent medical evaluation is required.

ELCARBONATE 450 SR should be used only under qualified medical supervision, with the treatment plan tailored to the individual's diagnosis, laboratory results, kidney function, and clinical response.

Comments

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness